Does Medicare cover GLP-1 medications for weight loss?

Medicare Part D generally does not cover GLP-1 medications when prescribed specifically for weight loss. The Medicare Modernization Act of 2003 explicitly excludes coverage for drugs used for weight loss or weight gain. This means Wegovy and Zepbound, which are FDA-approved for chronic weight management, are typically not covered under Medicare plans.

However, there may be limited exceptions. Ozempic and Mounjaro are FDA-approved for type 2 diabetes treatment, and some Medicare plans may cover them for this indication if diabetes is documented. Even then, coverage is not guaranteed and often requires prior authorization. Medicare Advantage plans may have different policies, but most follow federal guidelines excluding weight loss medications.